查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年北美痤疮药物市场预测 - 区域分析 - 按治疗类别、配方、类型、痤疮类型和配销通路
市场调查报告书
商品编码
1567795

2030 年北美痤疮药物市场预测 - 区域分析 - 按治疗类别、配方、类型、痤疮类型和配销通路

North America Acne Medication Market Forecast to 2030 - Regional Analysis - by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 121 Pages | 订单完成后即时交付

价格

2022年北美痤疮药物市值为33.625亿美元，预计到2030年将达到47.9401亿美元；预计 2023 年至 2030 年复合年增长率为 4.6%。

对有机和自然疗法的需求激增推动了北美痤疮药物市场

随着人们越来越意识到传统护肤产品中使用的合成成分和化学品的潜在有害影响，世界各地对被认为更安全、更温和、更环保的天然和有机替代品的需求正在增加。消费者越来越多地寻求不含刺激性化学物质、人造香料和潜在刺激性物质的产品，选择利用植物成分、植物萃取物、精油和其他以其护肤功效而闻名的天然化合物的配方。为了应对这一趋势，许多护肤品牌和製造商正在开发各种天然有机痤疮治疗产品，以满足注重健康的消费者的需求。这些产品通常含有茶树油、金缕梅、芦荟、绿茶萃取物和水杨酸等天然成分，提供更全面、更永续的痤疮治疗方法，同时又不影响功效。 2022年7月，有机护肤企业MADARA推出了两款新型天然日常护肤产品－微生物平衡保湿霜和不干燥洁面乳。该公司声称，这些产品是融合科学和自然而开发的，专门为不同肤色、容易长粉刺的人提供温和的治疗。这两款产品均采用天然、有机和纯素成分製成——北方杜松干细胞、发酵多醣、地衣和马黛茶萃取物——专门针对瑕疵，保持皮肤不受伤害。成人和青少年都可以使用该产品。因此，对天然和有机痤疮治疗方案的日益偏好预计将在未来几年继续塑造北美痤疮药物市场的未来。

日益严格的监管审查以及与行业标准相关的併发症也推动了向天然和有机痤疮治疗方案的转变。监管机构强调成分透明度、安全性和永续性，促使公司重新制定产品配方，以满足消费者对更清洁、更环保的护肤解决方案不断变化的偏好。因此，随着越来越多的消费者在日常护肤中优先考虑天然成分和环保配方，预计北美痤疮药物市场在未来几年将经历新的成长趋势。

北美痤疮药物市场概况

北美的痤疮药物市场分为美国、加拿大和墨西哥。到 2022 年，美国将占据北美最大的痤疮药物市场份额。根据美国皮肤病学会的数据，痤疮是美国最常见的疾病，每年有多达 5000 万美国人患有痤疮，使其成为全国最常见的皮肤病。由于美国人痤疮发病率的增加以及随后各种创新痤疮药物的推出，预计该国的痤疮药物市场将会扩大。

北美痤疮药物市场收入及 2030 年预测（百万美元）

北美痤疮药物市场细分

北美痤疮药物市场根据治疗类别、配方、类型、痤疮类型、配销通路和国家进行细分。

根据治疗类别，北美痤疮药物市场分为类维生素A、过氧化苯甲酰、抗生素、水杨酸等。 2022 年，类视黄醇细分市场占据最大份额。

从剂型来看，北美痤疮药物市场分为外用药物和口服药物。 2022 年，外用药物领域占据更大的份额。

按类型划分，北美痤疮药物市场分为处方药和非处方药。 2022 年，处方药细分市场将占据更大的份额。

根据痤疮类型，北美痤疮药物市场分为非发炎性痤疮和发炎性痤疮。 2022 年，发炎性痤疮部分占据了更大的份额。

就配销通路而言，北美痤疮药物市场分为药局和药局、零售店和电子商务。 2022 年，药局和药局细分市场占据最大份额。

根据国家/地区，北美痤疮药物市场分为美国、加拿大和墨西哥。 2022 年，美国主导北美痤疮药物市场。

Sun Pharmaceutical Industries Ltd、Teva Pharmaceutical Industries Ltd、Almirall SA、强生公司、Bausch Health Companies Inc、Centro Internacional de Cosmiatria SA de CV、Galderma SA、辉瑞公司、GSK Plc、Viatris Inc、Somar Sapi De CV 和 Italmex SA为北美公司、GSK Plc、Viatris Inc、Somar Sapi De CV 和 Italmex SA痤疮药物市场上的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美痤疮药物市场格局

  • PEST分析
  • 外用和口服药物的定价分析
  • 接受痤疮治疗的患者群

第 5 章：北美痤疮药物市场 - 主要市场动态

  • 主要市场驱动因素
    • 严重痤疮的盛行率不断增加
    • 新药上市
  • 主要市场限制
    • 与痤疮药物相关的副作用
  • 主要市场机会
    • 基于尖端技术和数据驱动策略的个人化治疗方案
  • 未来趋势
    • 对有机和自然疗法的需求激增
  • 驱动因素和限制的影响：

第 6 章：痤疮药物市场 - 北美市场分析

第 7 章：北美痤疮药物市场分析 - 按治疗类别

  • 类维生素A
  • 过氧化苯甲酰
  • 抗生素
  • 水杨酸
  • 其他的

第 8 章：北美痤疮药物市场分析 - 按配方

  • 外用药物
  • 口服药物

第 9 章：北美痤疮药物市场分析 - 按类型

  • 处方药
  • 非处方药

第 10 章：北美痤疮药物市场分析 - 按痤疮类型

  • 非发炎性痤疮
  • 发炎性痤疮

第 11 章：北美痤疮药物市场分析 - 按配销通路

  • 药局和药局
  • 零售店
  • 电子商务

第 12 章：北美痤疮药物市场 - 国家分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥

第 13 章：痤疮药物市场-产业格局

  • 概述
  • 痤疮药物市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述
  • Farmapiel 提供的产品与其他公司痤疮产品的比较

第 14 章：公司简介

  • Teva Pharmaceutical Industries Ltd
  • Almirall SA
  • Johnson & Johnson
  • Sun Pharmaceutical Industries Ltd
  • Bausch Health Companies Inc
  • Centro Internacional de Cosmiatria SA de CV
  • Galderma SA
  • Pfizer Inc
  • GSK Plc
  • Viatris Inc
  • Somar Sapi De CV
  • Italmex SA

第 15 章：附录

Product Code: BMIRE00030656

The North America acne medication market was valued at US$ 3,362.50 million in 2022 and is expected to reach US$ 4,794.01 million by 2030; it is estimated to register at a CAGR of 4.6% from 2023 to 2030.

Upsurge in Need for Organic and Natural Treatments Fuels North America Acne Medication Market

As people are becoming more conscious of the potentially harmful effects of synthetic ingredients and chemicals used in traditional skincare products, the demand for natural and organic alternatives that are deemed to be safer, gentler, and more environmentally friendly is on the rise across the world. Consumers are increasingly seeking products free from harsh chemicals, artificial fragrances, and potentially irritating substances, opting for formulations that harness the power of plant-based ingredients, botanical extracts, essential oils, and other natural compounds known for their skincare benefits. In response to this trend, many skincare brands and manufacturers are developing a wide range of natural and organic acne treatment products that cater to the needs of health-conscious consumers. These products often feature ingredients such as tea tree oil, witch hazel, aloe vera, green tea extract, and salicylic acid derived from natural sources, offering a more holistic and sustainable approach to treating acne without compromising efficacy. In July 2022, MADARA, an organic skincare business, introduced two new and natural everyday skincare products-a microbiome-balancing moisturizer and a non-drying face cleanser. The company claims that these products were developed by blending science and nature, and were specifically formulated to offer gentle treatment for people of different complexions, who are prone to acne. Both products are made with natural, organic, and vegan ingredients-Northern Juniper Stem Cells, fermented polysaccharides, and lichen and Mate tea extracts-which deal specifically with imperfections, keeping the skin unharmed. Adults and teenagers can both utilize this product. Thus, the increasing preference for natural and organic acne treatment options is expected to continue shaping the future of the North America acne medication market in the coming years.

The shift toward natural and organic acne treatment options is also driven by the increasing stringency of regulatory scrutiny and complications associated with industry standards. Regulatory agencies emphasize ingredient transparency, safety, and sustainability, prompting companies to reformulate their products to meet evolving consumer preferences for cleaner and greener skincare solutions. Thus, as more consumers prioritize natural ingredients and eco-friendly formulations in their skincare routines, the North America acne medication market is expected to experience new growth trends in the coming years.

North America Acne Medication Market Overview

The acne medication market in North America is segmented into the US, Canada, and Mexico. The US held the largest North American acne medication market share in 2022. Acne is a skin condition brought on by debris, oil, sebum, and dead skin cells clogging hair follicles. According to the American Academy of Dermatology, acne is the most prevalent illness in the US, up to 50 million Americans suffer from acne each year, making it the most common skin ailment in the country. The acne medication market in this country is projected to expand due to the increased incidence of acne in Americans and the subsequent launch of various innovative acne medications.

North America Acne Medication Market Revenue and Forecast to 2030 (US$ Million)

North America Acne Medication Market Segmentation

The North America acne medication market is segmented based on therapeutic class, formulation, type, acne type, and distribution channel, and country.

Based on therapeutic class, the North America acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.

In terms of formulation, the North America acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.

By type, the North America acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.

Based on acne type, the North America acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.

In terms of distribution channel, the North America acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.

Based on country, the North America acne medication market is categorized into US, Canada, and Mexico. The US dominated the North America acne medication market in 2022.

Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Centro Internacional de Cosmiatria SA de CV, Galderma SA, Pfizer Inc, GSK Plc, Viatris Inc, Somar Sapi De CV, and Italmex SA are some of the leading companies operating in the North America acne medication market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Acne Medication Market Landscape

  • 4.1 PEST Analysis
  • 4.2 Pricing Analysis of Topical and Oral Medication
  • 4.3 Patient Population Undergoing Acne Treatment

5. North America Acne Medication Market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Prevalence of Severe Acne
    • 5.1.2 Launch of Novel Drugs
  • 5.2 Key Market Restraints
    • 5.2.1 Side Effects Associated with Acne Medication
  • 5.3 Key Market Opportunities
    • 5.3.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies
  • 5.4 Future Trends
    • 5.4.1 Upsurge in Need for Organic and Natural Treatments
  • 5.5 Impact of Drivers and Restraints:

6. Acne Medication Market - North America Market Analysis

7. North America Acne Medication Market Analysis - by Therapeutic Class

  • 7.1 Retinoids
    • 7.1.1 Overview
    • 7.1.2 Retinoids: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Benzoyl Peroxide
    • 7.2.1 Overview
    • 7.2.2 Benzoyl Peroxide: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Antibiotics
    • 7.3.1 Overview
    • 7.3.2 Antibiotics: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Salicylic Acid
    • 7.4.1 Overview
    • 7.4.2 Salicylic Acid: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Acne Medication Market Analysis - by Formulation

  • 8.1 Topical Medication
    • 8.1.1 Overview
    • 8.1.2 Topical Medication: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Oral Medication
    • 8.2.1 Overview
    • 8.2.2 Oral Medication: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Acne Medication Market Analysis - by Type

  • 9.1 Prescription Medicine
    • 9.1.1 Overview
    • 9.1.2 Prescription Medicine: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Over-the-Counter Medicine
    • 9.2.1 Overview
    • 9.2.2 Over-the-Counter Medicine: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Acne Medication Market Analysis - by Acne Type

  • 10.1 Non-Inflammatory Acne
    • 10.1.1 Overview
    • 10.1.2 Non-Inflammatory Acne: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Inflammatory Acne
    • 10.2.1 Overview
    • 10.2.2 Inflammatory Acne: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Acne Medication Market Analysis - by Distribution Channel

  • 11.1 Pharmacies and Drug Stores
    • 11.1.1 Overview
    • 11.1.2 Pharmacies and Drug Stores: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.2 Retail Stores
    • 11.2.1 Overview
    • 11.2.2 Retail Stores: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.3 E-Commerce
    • 11.3.1 Overview
    • 11.3.2 E-Commerce: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12. North America Acne Medication Market - Country Analysis

  • 12.1 North America
    • 12.1.1 North America: Acne Medication Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.1 North America: Acne Medication Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.2 US
      • 12.1.1.3 US: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.3.1 US: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.3.2 US: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.3.3 US: Acne Medication Market Breakdown, by Type
        • 12.1.1.3.4 US: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.3.5 US: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.4 Canada
      • 12.1.1.5 Canada: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.5.1 Canada: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.5.2 Canada: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.5.3 Canada: Acne Medication Market Breakdown, by Type
        • 12.1.1.5.4 Canada: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.5.5 Canada: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.6 Mexico
      • 12.1.1.7 Mexico: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.7.1 Mexico: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.7.2 Mexico: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.7.3 Mexico: Acne Medication Market Breakdown, by Type
        • 12.1.1.7.4 Mexico: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.7.5 Mexico: Acne Medication Market Breakdown, by Distribution Channel

13. Acne Medication Market- Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Acne Medication Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview
  • 13.5 Product Offered by Farmapiel vs Other Companies Acne Products

14. Company Profiles

  • 14.1 Teva Pharmaceutical Industries Ltd
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Almirall SA
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Johnson & Johnson
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Sun Pharmaceutical Industries Ltd
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Bausch Health Companies Inc
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Centro Internacional de Cosmiatria SA de CV
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Galderma SA
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Pfizer Inc
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 GSK Plc
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Viatris Inc
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments
  • 14.11 Somar Sapi De CV
    • 14.11.1 Key Facts
    • 14.11.2 Business Description
    • 14.11.3 Products and Services
    • 14.11.4 Financial Overview
    • 14.11.5 SWOT Analysis
    • 14.11.6 Key Developments
  • 14.12 Italmex SA
    • 14.12.1 Key Facts
    • 14.12.2 Business Description
    • 14.12.3 Products and Services
    • 14.12.4 Financial Overview
    • 14.12.5 SWOT Analysis
    • 14.12.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. North America Acne Medication Market Segmentation
  • Table 2. Topical Medication
  • Table 3. Oral Medication
  • Table 4. Patient Population undergoing Acne Treatment from 2020-2023
  • Table 5. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Therapeutic Class
  • Table 6. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Formulation
  • Table 7. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 8. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Acne Type
  • Table 9. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 10. North America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 11. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 12. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 13. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 14. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 15. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 16. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 17. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 18. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 19. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 20. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 21. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 22. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 23. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 24. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 25. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 26. Recent Organic Growth Strategies in Acne Medication Market
  • Table 27. Recent Inorganic Growth Strategies in the Acne Medication Market
  • Table 28. Glossary of Terms, Acne Medication Market

List Of Figures

  • Figure 1. North America Acne Medication Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. North America Acne Medication Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Acne Medication Market Revenue (US$ Million), 2020-2030
  • Figure 6. North America Acne Medication Market Share (%) - by Therapeutic Class (2022 and 2030)
  • Figure 7. Retinoids: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Benzoyl Peroxide: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Antibiotics: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Salicylic Acid: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. North America Acne Medication Market Share (%) - by Formulation (2022 and 2030)
  • Figure 13. Topical Medication: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Oral Medication: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. North America Acne Medication Market Share (%) - by Type (2022 and 2030)
  • Figure 16. Prescription Medicine: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Over-the-Counter Medicine: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. North America Acne Medication Market Share (%) - by Acne Type (2022 and 2030)
  • Figure 19. Non-Inflammatory Acne: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Inflammatory Acne: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. North America Acne Medication Market Share (%) - by Distribution Channel (2022 and 2030)
  • Figure 22. Pharmacies and Drug Stores: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Retail Stores: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. E-Commerce: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. North America: Acne Medication Market - Country, 2022 (US$ Million)
  • Figure 26. North America: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 27. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 29. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. Growth Strategies in Acne Medication Market